Literature DB >> 16506410

Assessment of cannabis craving using the Marijuana Craving Questionnaire.

Stephen J Heishman1, Edward G Singleton.   

Abstract

Cannabis is the most widely used illicit drug in the United States, with 14.6 million current users. Cannabis-dependent individuals presenting for treatment typically report cannabis craving; however, the phenomenon has received little research attention. In the absence of a valid, multidimensional questionnaire to assess cannabis craving, we developed the Marijuana Craving Questionnaire (MCQ). The MCQ consists of four constructs or factors that characterize cannabis craving: compulsivity, emotionality, expectancy, and purposefulness. A separate score is calculated for each factor. The MCQ can be used to measure cue-elicited craving in a research setting or natural craving in cannabis-dependent individuals presenting for treatment. Either the 47-item or 12-item version can be used, and standardized instructions for completion of the MCQ should be given. The MCQ can be administered using a paper and pencil form or a computerized version. In a research setting, the MCQ should be administered immediately after cue presentation and repeated frequently to capture the full time course. In a treatment setting, the MCQ should be administered at intake and during and at the end of treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16506410     DOI: 10.1385/1-59259-999-0:209

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  14 in total

1.  Linkage analyses of stimulant dependence, craving, and heavy use in American Indians.

Authors:  Cindy L Ehlers; Ian R Gizer; David A Gilder; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-02       Impact factor: 3.568

2.  Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.

Authors:  Karen I Bolla; Suzanne R Lesage; Charlene E Gamaldo; David N Neubauer; Nae-Yuh Wang; Frank R Funderburk; Richard P Allen; Paula M David; Jean Lud Cadet
Journal:  Sleep Med       Date:  2010-08-03       Impact factor: 3.492

3.  Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.

Authors:  Eef L Theunissen; Nadia R P W Hutten; Natasha L Mason; Stefan W Toennes; Kim P C Kuypers; Eliza B de Sousa Fernandes Perna; Johannes G Ramaekers
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

4.  Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use.

Authors:  Romina Mizrahi; Miran Kenk; Ivonne Suridjan; Isabelle Boileau; Tony P George; Kwame McKenzie; Alan A Wilson; Sylvain Houle; Pablo Rusjan
Journal:  Neuropsychopharmacology       Date:  2013-12-24       Impact factor: 7.853

5.  Cue reactivity in young marijuana smokers: a preliminary investigation.

Authors:  Kevin M Gray; Steven D LaRowe; Himanshu P Upadhyaya
Journal:  Psychol Addict Behav       Date:  2008-12

6.  Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study.

Authors:  Cindy L Ehlers; Ian R Gizer; Cassandra Vieten; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

7.  Reactivity to cannabis cues in virtual reality environments.

Authors:  Patrick S Bordnick; Hilary L Copp; Amy Traylor; Ken M Graap; Brian L Carter; Alicia Walton; Mirtha Ferrer
Journal:  J Psychoactive Drugs       Date:  2009-06

8.  Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.

Authors:  Romina Mizrahi; Ivonne Suridjan; Miran Kenk; Tony P George; Alan Wilson; Sylvain Houle; Pablo Rusjan
Journal:  Neuropsychopharmacology       Date:  2012-11-08       Impact factor: 7.853

9.  Sleep disturbance in heavy marijuana users.

Authors:  Karen I Bolla; Suzanne R Lesage; Charlene E Gamaldo; David N Neubauer; Frank R Funderburk; Jean Lud Cadet; Paula M David; Antonio Verdejo-Garcia; Amy R Benbrook
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

10.  Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results.

Authors:  Evonne J Charboneau; Mary S Dietrich; Sohee Park; Aize Cao; Tristan J Watkins; Jennifer U Blackford; Margaret M Benningfield; Peter R Martin; Maciej S Buchowski; Ronald L Cowan
Journal:  Psychiatry Res       Date:  2013-09-12       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.